MTS Medication Technologies, created in 1984 (United States), from 10 sister brands and 395 competing brands. The MTS Medication Technologies brand is owned by Omnicell, a company listed in New York. The sector of MTS Medication Technologies is Healthcare Providers & Services.
Share price and profitability of the share Omnicell (MTS Medication Technologies)
Buy Omnicell share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Omnicell
(MTS Medication Technologies)
over 5 years*
USD 9.59
Stock market history Omnicell (MTS Medication Technologies)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
